Filing Details
- Accession Number:
- 0001209191-20-008865
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 17:11:54
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 17:11:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 17,032 shares | Avg. Price: $246.11 | Total Value: $4,191,771.36 |
| Number of Shares After Transactions: | 39,970 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-10 | 13,308 | $240.95 | 57,002 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,000 | $243.36 | 56,002 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 3,400 | $244.89 | 52,602 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 5,725 | $245.81 | 46,877 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 3,472 | $246.73 | 43,405 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 2,235 | $247.73 | 41,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,200 | $248.50 | 39,970 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $243.36 (range $242.88 to $243.79).
- Open market sales reported on this line occurred at a weighted average price of $244.89 (range $244.28 to $245.25).
- Open market sales reported on this line occurred at a weighted average price of $245.81 (range $245.29 to $246.24).
- Open market sales reported on this line occurred at a weighted average price of $246.73 (range $246.29 to $247.26).
- Open market sales reported on this line occurred at a weighted average price of $247.73 (range $247.36 to $248.28).
- Open market sales reported on this line occurred at a weighted average price of $248.50 (range $248.37 to $248.82).
Billionaire Hedge Funds
